These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18475891)

  • 1. Radioprotectant Activity of Dicopper(II) Tetrakis(3,5- Diisopropylsalicylate) and Manganese(II) bis(3,5- Diisopropylsalicylate) Alone and in Combination.
    Kuykendall Iii JA; Ebert Ii RH; El-Sayed LH; Roberson PK; Pham-Tran VA; Booth BL; Brooks T; Willingham WM; Sorenson JR
    Met Based Drugs; 1999; 6(2):127-34. PubMed ID: 18475891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiorecovery Activity of Dicopper(II) Tetrakis(3,5-Diiso propylsalicylate) Includes Recovery of Radiation-Induced Loss of Body Mass and Impaired Mouse Locomotion.
    Henderson RD; Henderson TD; Irving HJ; Sorenson JR
    Met Based Drugs; 1999; 6(2):121-6. PubMed ID: 18475890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-Regulation of Porcine Heart Diaphorase Reactivity by Trimanganese Hexakis(3,5-Diisopropylsalicylate), Mn(3)(3,5-DIPS)6, and Down-Regulation of Nitric Oxide Synthase Reactivity by Mn(3)(3,5-DIPS)(6) and Cu(II)(2)(3,5-DIPS)(4).
    Booth BL; Pitters E; Mayer B; Sorenson JR
    Met Based Drugs; 1999; 6(2):111-20. PubMed ID: 18475889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiorecovery activity of manganese(III)2(II)(mu 3-O)-(mu-3,5-diisopropylsalicylate)6.
    Henderson TD; Burt RL; Kaufman SE; Willingham WM; Sorenson JR
    Radiat Res; 1993 Oct; 136(1):126-9. PubMed ID: 8210328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper(II)(3,5-diisopropylsalicylate)2 accelerates recovery of B and T cell reactivity following irradiation.
    Soderberg LS; Barnett JB; Baker ML; Salari H; Sorenson RJ
    Scand J Immunol; 1987 Nov; 26(5):495-502. PubMed ID: 3500502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper(II)2(3,5-diisopropylsalicylate)4 stimulates hemopoiesis in normal and irradiated mice.
    Soderberg LS; Barnett JB; Baker ML; Chang LW; Salari H; Sorenson JR
    Exp Hematol; 1988 Aug; 16(7):577-80. PubMed ID: 3292276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioprotectant Activity of 5-Diethylsulfonamoylsalicylatocopper(II) in Gamma Irradiated Mice.
    Kuykendall Iii JA; Simmons Iii H; Irving HJ; Wear MA; Sorenson PG; Tipton LG; Maddox KM; Williams EL; Pham-Tran VA; Credit C; Chowdhury IL; Khan S; Tipton JB; Willingham WM; Sorenson JR
    Met Based Drugs; 1999; 6(2):135-41. PubMed ID: 18475892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postirradiation treatment with copper(II)2(3,5-diisopropylsalicylate)4 enhances radiation recovery and hemopoietic regeneration.
    Soderberg LS; Barnett JB; Baker ML; Salari H; Sorenson JR
    Exp Hematol; 1990 Aug; 18(7):801-5. PubMed ID: 2379545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-temperature crystal structures of tetrakis-mu-3,5-diisopropylsalicylatobis-dimethylformamidodico pper(II) and tetrakis-mu-3,5-diisopropylsalicylatobis-diethyletheratodicopp er(II) and their role in modulating polymorphonuclear leukocyte activity in overcoming seizures.
    Morgant G; Dung NH; Daran JC; Viossat B; Labouze X; Roch-Arveiller M; Greenaway FT; Cordes W; Sorenson JR
    J Inorg Biochem; 2000 Jul; 81(1-2):11-22. PubMed ID: 11001426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable superoxide dismutase (SOD)-mimetic ternary human serum albumin-Cu(II)(3,5-diisopropylsalicylate)2/Cu(II)2(3,5-diisopropylsalicylate)4 complexes in tissue distribution of the binary complex.
    Shuff ST; Chowdhary P; Khan MF; Sorenson JR
    Biochem Pharmacol; 1992 Apr; 43(7):1601-12. PubMed ID: 1567481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper complexes stimulate hemopoiesis and lymphopoiesis.
    Soderberg LS; Barnett JB; Sorenson JR
    Adv Exp Med Biol; 1989; 258():209-17. PubMed ID: 2626987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Cu(II) 3,5-diisopropylsalicylate with human serum albumin--an evaluation of spectroscopic data.
    Greenaway FT; Hahn JJ; Xi N; Sorenson JR
    Biometals; 1998 Jan; 11(1):21-6. PubMed ID: 9450314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of NADPH-diaphorase (nitric oxide synthase) may account for the pharmacological activities of Cu(II)2 (3,5-diisopropylsalicylate)4.
    Baquial JG; Sorenson JR
    J Inorg Biochem; 1995 Nov; 60(2):133-48. PubMed ID: 8530918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of 180 degree K of bis-3, 5-diisopropylsalicylatobisdimethylsulfoxidozinc(II) and the inhibition of seizures and polymorphonuclear leukocyte chemiluminescence.
    Morgant G; Viossat B; Daran JC; Roch-Arveiller M; Giroud JP; Nguyen HD; Sorenson JR
    J Inorg Biochem; 1998 May; 70(2):137-43. PubMed ID: 9666572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic distribution of 67Cu(II)2[3,5-diisopropyl(carboxy-14C)salicylate]4 among murine tissues.
    Blincoe C; Chidambaram M; Salari H; Bond KB; Evans DT; Gray-Kaufman RA; Griffey HB; Tranby SG; Garner-Johnson B; Lee T; Sorenson JR
    Curr Med Chem; 2004 Nov; 11(22):3007-15. PubMed ID: 15544486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium(II)(3) (3,5-Diisopropylsalicylate)(6)(H(2)O)(6) Activates Nitric Oxide Synthase: An Accounting for its Action in Decreasing Platelet Aggregation.
    Donham DC; Sorenson JR
    Met Based Drugs; 2000; 7(2):77-88. PubMed ID: 18475929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and haematological results of rat skin burn injury treatment with Cu(II)2(3,5-diisopropylsalicylate)4.
    Malakyan MH; Bajinyan SA; Abrahamyan AK; Petrosyan ZH; Harutyunyan NK; Badiryan VA; Sorenson JR
    Inflammopharmacology; 2004; 12(4):321-51. PubMed ID: 15901413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression.
    Homoncik M; Jilma B; Donham DC; Frossard M; Keuzer C; Sorenson JR
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):131-8. PubMed ID: 12632022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of cytotoxicities and antimutagenic and antitumor initiating activities of Cu(II)(3,5-diisopropylsalicylate)2 and its analogs in a keratinocyte-mediated mutation assay and the murine skin multistage carcinogenesis model.
    Reiners JJ; Colby AB
    Carcinogenesis; 1988 Apr; 9(4):629-32. PubMed ID: 3128407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, crystal structures, and anti-convulsant activities of ternary [Zn(II)(3,5-diisopropylsalicylate)(2)], [Zn(II)(salicylate)(2)] and [Zn(II)(aspirinate)(2)] complexes.
    Lemoine P; Viossat B; Dung NH; Tomas A; Morgant G; Greenaway FT; Sorenson JR
    J Inorg Biochem; 2004 Nov; 98(11):1734-49. PubMed ID: 15522401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.